Candel Therapeutics, INC. (CADL) SEC Filings — 2025

Filings

• Candel Therapeutics Files 8-K — 8-K · Dec 5, 2025
• Candel Therapeutics Narrows Loss Amid R&D Spend, Cash Burn Continues — 10-Q · Nov 13, 2025
• Candel Therapeutics Files 8-K with Material Agreements and Financial Updates — 8-K · Oct 14, 2025
• Candel Therapeutics Enters Material Definitive Agreement — 8-K · Aug 21, 2025
• CADL Swings to Profit on Warrant Revaluation, Boosts Capital — 10-Q · Aug 14, 2025
• Candel Therapeutics Files 8-K: Material Agreement — 8-K · Jun 24, 2025
• Candel Therapeutics Files 8-K on Officer/Director Changes — 8-K · Jun 23, 2025
• Candel Therapeutics Reports on Shareholder Vote Outcomes — 8-K · Jun 18, 2025
• Candel Therapeutics Reports Officer/Director Changes — 8-K · Jun 6, 2025
• Candel Therapeutics Files 8-K Report — 8-K · May 28, 2025
• Candel Therapeutics Files 8-K — 8-K · May 22, 2025
• Candel Therapeutics Files Q1 2025 10-Q — 10-Q · May 13, 2025
• Candel Therapeutics Files 2025 Proxy Statement — DEF 14A · Apr 29, 2025
• Candel Therapeutics Files 8-K — 8-K · Apr 23, 2025
• Candel Therapeutics Files 8-K — 8-K · Mar 27, 2025
• Candel Therapeutics Files 2024 10-K — 10-K · Mar 13, 2025
• Candel Therapeutics Files 8-K — 8-K · Feb 25, 2025
• Candel Therapeutics Files 8-K on Financials and Operations — 8-K · Jan 13, 2025